Eli Lilly acquires three vaccine developers for $3.8 billion

Name: Eli Lilly acquires three vaccine developers for $3.8 billion
Uploaded: 2026-05-26T14:57:13Z
Duration: 32 s
Description: Lauren Simonetti reports on Eli Lilly's acquisition of three vaccine developers for a combined $3.8 billion. The acquisitions target companies working on vaccines for staff infections, Epstein-Barr, and shingles, signaling Eli Lilly's strategic expansion into the infectious diseases market.

Varney & Company · FBN · May 26, 2026 · 32s

Sign Up Now

Already a subscriber?

Lauren Simonetti reports on Eli Lilly's acquisition of three vaccine developers for a combined $3.8 billion. The acquisitions target companies working on vaccines for staff infections, Epstein-Barr, and shingles, signaling Eli Lilly's strategic expansion into the infectious diseases market.